Reproductive toxicity of emerging plasticizers, flame retardants, and bisphenols, using culture of the rat fetal testisdagger
Individuals with T2DM frequently have multiple cardiovascular risk factors, including obesity (32.9%), hypertension (32-80%), and dyslipidemia (39%) ( The association between glycemic control and cardiovascular outcomes in DM patients has been long studied ( To address these challenges, novel pharmacological therapies such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged, offering cardioprotective benefits ( The aim of this review is to enhance our understanding of the role of SGLT-2i and GLP-1 RAs in managing patients with T2DM and CVD
The FAK-paxillin pathway regulates this migratory capacity, and BPC-157 has been shown to activate this system in dose-dependent fashion
That is why our program is built on the core principle of being: Medically Supervised: Safety is paramount
10.1111/cns.14604 124 WangX.HuM.ChenJ.LouX.ZhangH.LiM.et al (2024)
